Hong Kong-listed firm leverages AI to transform traditional drug discovery approach | South China Morning Post

Chief scientific officer at XtalPi says AI can cut average drug discovery times to one to two years

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.